Assignee
CAN FITE BIOPHARMA LTD
NL·17 granted patents·15 pending applications·86 citations·filing 1998–2025
Top patents by PatentIndex Score
32 records- 0188US7825102B2Treatment of dry eye conditionsCAN FITE BIOPHARMA LTD·Filed 2006·Granted Nov 2, 2010·13 cites·15 claims
- 0283US9387220B2Method for inducing hepatocyte proliferation and uses thereofCAN FITE BIOPHARMA LTD·Filed 2014·Granted Jul 12, 2016·7 cites·19 claims
- 0382US7589075B2Use of an adenosine A3 receptor agonist for inhibition of viral replicationCAN FITE BIOPHARMA LTD·Filed 2002·Granted Sep 15, 2009·12 cites·16 claims
- 0480US6638914B1Pharmaceutical administration of adenosine agonistsCAN FITE BIOPHARMA LTD·Filed 2000·Granted Oct 28, 2003·18 cites·14 claims
- 0579US10265337B2Use of A3 adenosine receptor agonist in osteoarthritis treatmentCAN FITE BIOPHARMA LTD·Filed 2016·Granted Apr 23, 2019·2 cites·13 claims
- 0670US7064112B1Pharmaceutical compositions comprising an adenosine receptor agonist or antagonistCAN FITE BIOPHARMA LTD·Filed 2000·Granted Jun 20, 2006·15 cites·38 claims
- 0770US6790839B2Pharmaceutical administration of adenosine agonistsCAN FITE BIOPHARMA LTD·Filed 2001·Granted Sep 14, 2004·3 cites·11 claims
- 0865US11291681B2Method for treating fibrotic liver tissue using Cl-IB-MECACAN FITE BIOPHARMA LTD·Filed 2020·Granted Apr 5, 2022·0 cites·8 claims
- 0964US10780106B2Method for treating NASH accompanied by fibrosis using Cl-IB-MECACAN FITE BIOPHARMA LTD·Filed 2018·Granted Sep 22, 2020·0 cites·6 claims
- 1064US7084127B2C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different usesCAN FITE BIOPHARMA LTD·Filed 2002·Granted Aug 1, 2006·5 cites·29 claims
- 1163US7465715B2Method for treatment of multiple sclerosisCAN FITE BIOPHARMA LTD·Filed 2004·Granted Dec 16, 2008·5 cites·4 claims
- 1263US7189706B2C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing themCAN FITE BIOPHARMA LTD·Filed 2003·Granted Mar 13, 2007·4 cites·29 claims
- 1363US2025387424A1Pharmaceutical composition comprising a3 adenosine receptor agonist for treatment of psoriasisCAN FITE BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 1461US2023201240A1Treatment of advanced metastatic cancerCAN FITE BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 1558US2025368676A1Process for preparing namodenosonCAN FITE BIOPHARMA LTD·Filed 2025·Application pending·0 cites
- 1651US2005101560A1Method of treating an individual with methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl] beta-D-ibofuronamideCAN FITE BIOPHARMA LTD·Filed 2003·Application pending·0 cites
- 1748US2013345163A1Biological marker for inflammationCAN FITE BIOPHARMA LTD·Filed 2013·Application pending·0 cites
- 1847US2005277615A1Pharmaceutical compositions having anti-inflammatory activityCAN FITE BIOPHARMA LTD·Filed 2004·Application pending·0 cites
- 1947US2008056992A1Biological Marker for InflammationCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 2045US2023049415A1Cannabinoids for use in treatmentCAN FITE BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 2144US9549943B2A3 adenosine receptor ligands for use in treatment of a sexual dysfunctionCAN-FITE BIOPHARMA LTD·Filed 2013·Granted Jan 24, 2017·0 cites·17 claims
- 2244US2008051365A1Treatment of InflammationCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 2344US2021069227A1A3 adenosine receptor ligand for managing cytokine release syndromeCAN FITE BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 2442US12213990B2A3 adenosine receptor ligand for use for achieving a fat loss effectCAN FITE BIOPHARMA LTD·Filed 2020·Granted Feb 4, 2025·0 cites·5 claims
- 2540US6537587B1Compositions containing muscle-derived active agentsCAN FITE BIOPHARMA LTD·Filed 2000·Granted Mar 25, 2003·0 cites·5 claims
- 2639US2006084626A1Pharmaceutical compositions comprising an adenosine receptor agonist or antagonistCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
- 2738US2004137477A1A3AR as a marker for a diseased stateCAN FITE BIOPHARMA LTD·Filed 2003·Application pending·0 cites
- 2838US2010222369A1Treatment for dry eye conditionsCAN FITE BIOPHARMA LTD·Filed 2010·Application pending·0 cites
- 2936US6911435B1Method of treating leukopenia with adenosineCAN FITE BIOPHARMA LTD·Filed 1998·Granted Jun 28, 2005·2 cites·15 claims
- 3035US2015018299A1Treatment of liver conditionsCAN FITE BIOPHARMA LTD·Filed 2013·Application pending·0 cites
- 3134US7112574B2C2,8-disubstituted adenosine derivatives and their different usesCAN FITE BIOPHARMA LTD·Filed 2002·Granted Sep 26, 2006·0 cites·25 claims
- 3234US2006241069A1Treatment of hyperproliferative diseaseCAN FITE BIOPHARMA LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CAN FITE BIOPHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →